BML, Inc.
JPX: 4694.T0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Tokyo Stock Exchange
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Kensuke Kondo
- Employees
- 4,513
- Headquarters
- Tokyo, Japan
- IPO year
- 2001
- Market cap
- ¥143.4B
- Website
- https://www.bml.co.jp
Loading 4694…
Loading profile data…Frequently asked questions about 4694
What does BML, Inc. (4694.T) do?
BML, Inc. provides laboratory testing and related services in Japan. The company offers general laboratory tests, including biochemical and hematologic examinations; special laboratory tests, such as RIA, cellular, immunological, and DNA analysis; microbiological tests for medical and pharmaceutical societies and organizations; and laboratory te...
Where does 4694.T trade?
BML, Inc. (4694.T) trades on the Tokyo Stock Exchange.
What sector is 4694.T in?
BML, Inc. (4694.T) operates in the Healthcare sector, specifically in the Medical - Diagnostics & Research industry.
Who is the CEO of BML, Inc.?
Kensuke Kondo is the chief executive officer of BML, Inc. (4694.T).
Where is BML, Inc. headquartered?
BML, Inc. is headquartered in Japan.
Does 4694.T pay a dividend?
Yes — BML, Inc. (4694.T) paid a trailing twelve-month dividend of JPY 120.00 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 4694.T go public?
BML, Inc. (4694.T) completed its initial public offering in 2001.